SOURCE: Horizon Pharma plc

Horizon Pharma plc

September 09, 2015 07:00 ET

Horizon Pharma plc to Present at the Morgan Stanley Global Healthcare Conference

DUBLIN, IRELAND--(Marketwired - Sep 9, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Chairman, President and Chief Executive Officer Timothy P. Walbert will participate in a fireside chat discussion at the Morgan Stanley Global Healthcare Conference in New York on Thursday, September 17th at 5:15 p.m. Eastern Time. Mr. Walbert will provide an overview of Horizon Pharma's business as well as recent and proposed transactions.

The discussion will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contact Information